🔥🐔 BizChicken 🐔🔥
Companies Similar to Precigen, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Gain Therapeutics, Inc.
Site-Directed Enzyme Enhancement Therapy platform
Gain Therapeutics, Inc. is a biotechnology company developing therapies for diseases caused by protein misfolding, focusing on rare genetic diseases and neurological disorders. It utilizes its proprietary technology to discover and develop molecules targeting misfolded proteins.
Symbol: GANX
Recent Price: $2.18
Industry: Biotechnology
CEO: Mr. Gene Mack M.B.A.
Sector: Healthcare
Employees: 29
Address: 4800 Montgomery Lane, Bethesda, MD 20814
Phone: 301 500 1556
Last updated: 2024-12-31
ImmunityBio, Inc.
Therapies and Vaccines
Immunity Bio, Inc. is a clinical-stage biotechnology company developing therapies and vaccines to treat cancers and infectious diseases, with a focus on immunotherapy and cell therapy platforms. The company collaborates with several institutes and has multiple therapeutic agents in clinical trials.
Symbol: IBRX
Recent Price: $2.68
Industry: Biotechnology
CEO: Mr. Richard Gerald Adcock
Sector: Healthcare
Employees: 622
Address: 3530 John Hopkins Court, San Diego, CA 92121
Phone: 858 633 0300
Last updated: 2024-12-31
Mustang Bio, Inc.
Gene and CAR T Cell Therapies
Mustang Bio, Inc. is a biopharmaceutical company specializing in cell and gene therapies for hematologic cancers, solid tumors, and rare genetic diseases. It focuses on developing gene therapy programs and CAR T cell therapies, including treatments for X-linked severe combined immunodeficiency and various types of cancer.
About | Leadership | Directors | News | Contact | About | About | Careers | About | About | Careers | About | About
Symbol: MBIO
Recent Price: $0.19
Industry: Biotechnology
CEO: Dr. Manuel Litchman M.D.
Sector: Healthcare
Employees: 80
Address: 377 Plantation Street, Worcester, MA 01605
Phone: 781 652 4500
Leadership
- Manuel Litchman, M.D., President, Chief Executive Officer and Director
- Greg Furrow, M.S., FRQA, Chief Quality Officer
- James Murphy, B.A., Ad interim Chief Financial Officer
- Michael S. Weiss, Chairman of the Board of Directors
- Lindsay A. Rosenwald, M.D., Director
- Adam J. Chill, Director
- Neil Herskowitz, Director
- Michael J. Zelefsky, M.D., Director
- Mustang Bio, Inc., Company
Last updated: 2024-12-31
Precigen, Inc.
gene and cellular therapies
Precigen, Inc. is focused on discovering and developing advanced gene and cellular therapies, disease-modifying therapeutics, and genetic engineering technologies for regenerative medicine and other applications.
About | Contact | Careers | Careers | Careers | About | About | Benefits | Careers | About | About | About | Careers | Careers | About
Symbol: PGEN
Recent Price: $0.93
Industry: Biotechnology
CEO: Dr. Helen Sabzevari MPH, Ph.D.
Sector: Healthcare
Employees: 202
Address: 20374 Seneca Meadows Parkway, Germantown, MD 20876
Phone: 301 556 9900
Last updated: 2024-12-31
Precipio, Inc.
IV-Cell, Heme Screen, ICE-COLD PCR
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States, specializing in diagnostic blood cancer testing services, cell culture media, genetic diagnostic panels, and COVID-19 antibody tests.
Careers | About | Culture | News | About | Leadership | Directors | Contact | About | Careers | About | About | ESG | About | About | About | About | About | About | About | About
Symbol: PRPO
Recent Price: $5.80
Industry: Medical - Diagnostics & Research
CEO: Mr. Ilan Danieli
Sector: Healthcare
Employees: 51
Address: 4 Science Park, New Haven, CT 06511
Phone: 203 787 7888
Leadership
- Ilan Danieli, Director
- Ayman Mohamed, MD, CTO
- Miri Chiko-Radomski, Chief Legal Counsel and People Officer
- A. Zaki Sabet, COO
- Matthew Gage, CFO
- Richard Sandberg, Chairman of the Board
- Kathy LaPorte, Director
- Ron A. Andrews (Ronnie), Director
- David S. Cohen, Director
- Jeffrey Cossman, MD, Director
- Christina Valauri, Director
Last updated: 2024-12-31
Telomir Pharmaceuticals, Inc. Common Stock
TELOMIR-1
Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on developing and commercializing therapies for age-related inflammatory conditions and post-chemotherapy recovery.
Symbol: TELO
Recent Price: $4.64
Industry: Biotechnology
CEO: Mr. Erez Aminov
Sector: Healthcare
Employees: 1
Address: 855 N Wolfe Street, Baltimore, null 21205
Phone: (737)-289-0835
Last updated: 2024-12-31
Agenus Inc.
Retrocyte Display
Agenus Inc. is a clinical-stage immuno-oncology company that discovers and develops immuno-oncology products, offering antibody expression platforms, vaccine programs, and various monoclonal antibodies for cancer treatment.
Symbol: AGEN
Recent Price: $2.69
Industry: Biotechnology
CEO: Dr. Garo H. Armen Ph.D.
Sector: Healthcare
Employees: 389
Address: 3 Forbes Road, Lexington, MA 02421-7305
Phone: 781 674 4400
Last updated: 2024-12-31
Beam Therapeutics Inc.
precision genetic medicines
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States, with a focus on conditions such as sickle cell disease, beta thalassemia, and Glycogen Storage Disease Type Ia.
About | Contact | Careers | Careers | Careers | Careers | Jobs | Careers | About | About | About | Careers | About | Jobs | Careers
Symbol: BEAM
Recent Price: $25.28
Industry: Biotechnology
CEO: Mr. John M. Evans M.B.A.
Sector: Healthcare
Employees: 472
Address: 238 Main Street, Cambridge, MA 02142
Phone: 857 327 8775
Last updated: 2024-12-31
Celcuity Inc.
CELsignia diagnostic platform
Celcuity Inc., a biotechnology company, develops targeted therapies for cancer patients in the US, including the CELsignia diagnostic platform and Gedatolisib drug candidate.
Symbol: CELC
Recent Price: $13.13
Industry: Biotechnology
CEO: Mr. Brian F. Sullivan
Sector: Healthcare
Employees: 55
Address: 16305–36th Avenue North, Minneapolis, MN 55446
Phone: 763 392 0767
Leadership
- Brian Sullivan, CEO and Co-founder
- Lance Laing, PhD, Chief Science Officer and Co-founder
- Vicky Hahne, CFO
- Igor Gorbatchevsky, MD, Chief Medical Officer
- Eldon Mayer, Chief Commercial Officer
- Brent Eilefson, General Counsel
- Bernhard Lampert, PhD, VP of Pharmaceutical Development
- Nadene Zack, VP Clinical Operations
- Sunni Miller, VP of Regulatory Affairs
- David Bridge, VP of Quality Assurance and Process Development
- William Strickland, PharmD, VP of Medical Affairs
- Fred Kerwood, VP of Program Management
- Charlotte Moser, MD, PhD, SVP of Clinical Development
- John R. MacDonald, PhD, SVP of R&D
- Lance Laing, PhD, Chief Science Officer and Co-Founder
- Richard Buller, MD, PhD, Director
- David F. Dalvey, Director
- Leo Furcht, MD, Director
- Polly Murphy, DVM, PhD, Director
- Richard J. Nigon, Director
Last updated: 2024-12-31
Celularity Inc.
CYCART-19, CYNK-001, CYNK-101, APPL-001, PDA-002
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and Bio Banking.
About | Leadership | Directors | About | About | About | About | Directors | Careers | About | About | About | About | About | About
Symbol: CELU
Recent Price: $2.05
Industry: Biotechnology
CEO: Dr. Robert Joseph Hariri M.D., Ph.D.
Sector: Healthcare
Employees: 120
Address: 170 Park Avenue, Florham Park, NJ 07932
Phone: 908 768 2170
Leadership
- Robert J. Hariri, M.D., Ph.D., Chairperson, Founder, and CEO
- David Beers, CFA, Chief Financial Officer
- Stephen Brigido, DPM, President, Degenerative Diseases
- John Haines, Global Manager and Chief Administrative Officer
- K. Harold Fletcher, Esq., General Counsel & Chief Compliance Officer
- John Colerangle, DVM, Ph.D., Regulatory Affairs
- Anna Gosiewska, Ph.D., R&D, Degenerative Diseases
- Sharmila Koppisetti, M.D., Clinical Development Immunology & Drug Safety
- Carmine Palummo, Corporate Operations
- Tim Wilk, Technical Operations
- Robert J. Hariri, M.D., Ph.D, Chairperson, Founder & CEO
- Peter Diamandis, M.D., Director
- Dean Kehler, Director
- Geoffrey Shiu Fei Ling, M.D., Ph.D., Director
- Diane Parks, Director
Last updated: 2024-12-31
Cogent Biosciences, Inc.
CGT9486
Cogent Biosciences, Inc. is a biotechnology company focused on developing precision therapies for genetically defined diseases, with lead product candidate CGT9486 targeting mutations driving systemic mastocytosis and advanced gastrointestinal stromal tumors.
Symbol: COGT
Recent Price: $7.67
Industry: Biotechnology
CEO: Mr. Andrew R. Robbins M.B.A.
Sector: Healthcare
Employees: 164
Address: 200 Cambridge Park Drive, Cambridge, MA 02140
Phone: 617 945 5576
Last updated: 2024-12-31
Precision BioSciences, Inc.
ARCUS
Precision Bio Sciences, Inc. is a clinical stage gene editing company specializing in in vivo gene editing and ex vivo allogeneic CAR T therapies, including the ARCUS genome editing platform and various investigational CAR T immunotherapies.
Contact | Careers | Careers | Careers | Careers | Leadership | Leadership | Leadership | Careers | Careers | About | About | About
Symbol: DTIL
Recent Price: $4.26
Industry: Biotechnology
CEO: Mr. Michael Amoroso
Sector: Healthcare
Employees: 109
Address: 302 East Pettigrew Street, Durham, NC 27701
Phone: 919 314 5512
Last updated: 2024-12-31
Generation Bio Co.
genetic medicines
Generation Bio Co. is a genetic medicines company developing therapies for rare and prevalent diseases, with a focus on the liver, retina, skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and is headquartered in Cambridge, Massachusetts.
Symbol: GBIO
Recent Price: $1.06
Industry: Biotechnology
CEO: Dr. Cameron Geoffrey McDonough M.D.
Sector: Healthcare
Employees: 174
Address: 301 Binney Street, Cambridge, MA 02142
Phone: 617 655 7500
Last updated: 2024-12-31
Neurogene Inc.
NGN-401, NGN-101
Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases, focusing on gene therapy products like NGN-401 for Rett syndrome and NGN-101 for neuronal ceroid lipofuscinosis subtype 5 batten disease.
About | Contact | Contact | Careers | Jobs | Jobs | Jobs | Benefits | Jobs | Jobs | Jobs | Jobs | Careers | About | About | About
Symbol: NGNE
Recent Price: $22.28
Industry: Biotechnology
CEO: Dr. Rachel L. McMinn Ph.D.
Sector: Healthcare
Employees: 91
Address: 535 W 24th Street, New York, NY 10011
Phone: (877) 237-5020
Last updated: 2024-12-31
2seventy bio, Inc.
idecabtagene vicleucel
2seventy bio, Inc. is a cell and gene therapy company focusing on cancer treatment research, development, and commercialization, with products including idecabtagene vicleucel and collaborations with Bristol-Myers Squibb.
Symbol: TSVT
Recent Price: $2.89
Industry: Biotechnology
CEO: Mr. William D. Baird III, M.B.A.
Sector: Healthcare
Employees: 274
Address: 60 Binney Street, Cambridge, MA 02142
Phone: 339 499 9300
Last updated: 2024-12-31
Tevogen Bio Holdings Inc.
TVGN 489
Tevogen Bio Holdings Inc. is a clinical-stage biotechnology company developing off-the-shelf precision T cell therapeutics focusing on virology, oncology, and neurology, with a key focus on COVID-19 and long COVID treatments.
About | News | News | News | About | News | News | Contact | About | About | Careers | About | About | About | About | About | About | About
Symbol: TVGN
Recent Price: $1.05
Industry: Biotechnology
CEO: Dr. Ryan H. Saadi M.D., M.P.H, M.P.H.
Sector: Healthcare
Employees: 17
Address: 15 Independence Blvd, Warren, NJ 07059
Phone: 877 838 6436
Last updated: 2024-12-31
Verve Therapeutics, Inc.
VERVE-101
Verve Therapeutics, Inc. is a genetic medicines company developing gene editing treatments for cardiovascular diseases, primarily through its lead product VERVE-101.
Symbol: VERV
Recent Price: $5.54
Industry: Biotechnology
CEO: Dr. Sekar Kathiresan M.D.
Sector: Healthcare
Employees: 255
Address: 500 Technology Square, Cambridge, MA 02139
Phone: 617 603 0070
Leadership
- Andrew Ashe, President, Chief Operating Officer and General Counsel
- Victoria Bartlett, Vice President, Program and Alliance Management
- Dan Balian, Associate Director, Supply Chain Management
- Allen Barrett, Director, Corporate Counsel
Last updated: 2024-12-31
Abeona Therapeutics Inc.
EB-101
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa.
Symbol: ABEO
Recent Price: $5.61
Industry: Biotechnology
CEO: Dr. Vishwas Seshadri M.B.A., Ph.D.
Sector: Healthcare
Employees: 84
Address: 1330 Avenue of the Americas, New York, NY 10019
Phone: 646 813 4701
Last updated: 2024-12-31
Creative Medical Technology Holdings, Inc.
Imm Celz
Creative Medical Technology Holdings, Inc. is a biotechnology company focusing on using adult stem cell treatments for immunology, urology, orthopedics, and neurology, offering solutions like Caver Stem, Fem Celz, Stem Spine, Imm Celz, and Ova Stem.
Symbol: CELZ
Recent Price: $2.34
Industry: Biotechnology
CEO: Mr. Timothy Warbington
Sector: Healthcare
Employees: 4
Address: 211 East Osborn Road, Phoenix, AZ 85012
Phone: 480 399 2822
Last updated: 2024-12-31
Orgenesis Inc.
Point of Care (POCare) platform
Orgenesis Inc. is a biotech company focusing on cell and gene therapies. It offers a Point of Care (POCare) platform with a pipeline of POCare therapeutics produced in automated systems, targeting autologous therapies near the patient's point of care.
About | Contact | Careers | Careers | Careers | Careers | Careers | Contact | Careers | Careers | Careers | Careers | Careers | Careers | News | Careers | Directors | Careers | Careers | Careers | Careers | Careers | About | About | About
Symbol: ORGS
Recent Price: $2.11
Industry: Biotechnology
CEO: Ms. Vered Caplan M.Sc.
Sector: Healthcare
Employees: 146
Address: 20271 Goldenrod Lane, Germantown, MD 20876
Phone: 480 659 6404
Last updated: 2024-12-31